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57 ABSTRACT 
A cell culture substrate which promotes cell adhesion 
and the formation of focal contacts is disclosed. Poly 
mer, ceramic and glass surfaces may be used. The sur 
faces are derivatized with peptides having less than 12 
amino acid residues and containing one of the following 
sequences of amino acids: GRGD, GYIGSR, GREDV. 
The peptides are covalently attached to the surface 
through the terminal amino group of the N-terminal 
glycine residue, and are effective at concentrations of 
about 50 picomoles or less per cm2 of surface area. 
Methods of preparing the surfaces are disclosed. 
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CHEMICAL MODIFICATION OF PROMOTE 
ANIMAL CELL ADHESION ON SURFACEs. 
The U.S. Government may have rights in the present 
invention as relevant developmental work was sup 
ported by National Science Foundation Grant CBT 
881020268, and National Institutes of Health Grant 
HL-39714. 
Reference is specifically made herein the copending 
application, U.S. Ser. No. 07/527,198, filed May 21, 
1990. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The field of the present invention relates generally to 
the biospecific adhesion of cells to a surface. More spe 
cifically, the invention relates to the chemical modifica 
tion of a surface and the covalent attachment thereto of 
small peptides to promote cell adhesion. Even more 
particularly, the surface may comprise a ceramic, a 
metal or a polymer. The small peptides include a mini 
mal cell receptor recognition amino acid sequence 
which promotes cell adhesion and is common to a vari 
ety of cell adhesion molecules. The surfaces and meth 
ods of the present invention thus relate to cell adhesion 
techniques which are independent of culture media 
serum composition and adsorbed surface proteins. 
2. Description of the Related Art 
The interaction of cells with extracellular matrix in 
vivo is involved in a number of important biological 
processes, such as the regulation of cellular growth, 
migration, and differentiation. The role of eukaryotic 
cell adhesion in culture largely dictates the success of a 
particular cell culture effort or endeavor. Adhesion, 
spreading, and contraction on solid substances are pre 
requisites for growth of normal anchorage dependent 
cells in vitro (1,2). This cellular bioadhesion is affected 
by several factors, including the particular type of cell, 
the cell culture media used, and the particular surface 
upon which the cells are cultured. 
Many mammalian cells are cultured on polymer sur 
faces. Nearly all mammalian cell adhesion to synthetic 
polymer surfaces is controlled by adsorbed proteins and 
is receptor mediated. Fibronectin (FN), was the first 
cell adhesion molecule (CAM) that was shown to be 
involved in the adhesion of some avian and mammalian 
cell types to extracellular substrates (3, 4). FN is com 
monly provided to the in vitro environment through the 
addition of serum, in a form known as cold-insoluble 
globulin (CIg). For normal attachment and spreading of 
cells to occur, it was found that CIg had to be adsorbed 
to the culture surface (5, 6). 
FN consists of several protease-resistant domains, 
each of which contain specific binding sites for other 
extra cellular molecules and for the cell surface (7). The 
cell attachment activity has been localized to a tripep 
tide sequence (RGD), located in the cell binding do 
main of FN as well as in several other CAMs (8). Sub 
strate-bound, RGD-containing peptide, directly ad 
sorbed to the substrate, or peptide cross-linked to ad 
sorbed albumin or IgG, was found to promote fibroblast 
attachment and spreading. This attachment and spread 
ing activity was found to be readily inhibited by the 
addition of soluble RGD-containing peptides to the 
medium (8). 
Affinity chromatography of cellular extracts on cell 












specific elution utilizing synthetic RGD-containing 
peptides yielded a receptor with two 140 kD subunits 
(9). The mammalian FN receptor and other RGD di 
rected receptors are typically heterodimers of two sub 
units, alpha and beta (10). Families of these receptors 
consist of members with similar beta subunits, whereas 
the alpha subunits are more distinct and restrict the 
receptor's affinity to one or a few CAMs (11). Collec 
tively, these structurally and functionally related recep 
tor families are known as the integrin superfamily (12, 
13). 
A basic understanding of the molecular mechanisms 
underlying the process of cell adhesion has thus devel 
oped regarding the role of the cell culture substrates 
and other surfaces in promoting cell adhesion. Basi 
cally, after a protein solution is placed on a culture 
substrate, proteins are immediately adsorbed to the 
surface. If there are receptors for some of these ad 
sorbed proteins on the cell surface, and if the conforma 
tion of the adsorbed protein is not so extensively altered 
by adsorption as to destroy the high ligand-receptor 
affinity, then cell adhesion to the culture substrate and 
cell spreading can result. 
If the cells are seeded on a substrate in the absence of 
adsorbed proteins, then the proteins on the cell surface 
may directly adsorb to the surface and the cell will, 
provided favorable conditions, secrete its own proteins 
toward the surface in the form of an extracellular ma 
trix. However, if the substrate does not support protein 
adsorption, or if it supports high affinity adsorption of a 
protein for which there is not a cell-surface receptor, 
then the substrate will not support cell adhesion. In no 
case has the cell in culture been found to actually touch 
the surface except through these intermediate adsorbed 
proteins. 
Some investigators who study short-term cell adhe 
sion have proposed the use of substrate treating systems 
which promote cell adhesion wherein particular pep 
tides are adsorbed to a polymer surface. For example, 
Singer, et al. proposed the adsorption of a 13-mer pep 
tide containing the RGD sequence onto a polymer sub 
strate to promote cell adhesion (14). However, peptides 
of this length have been found to be highly susceptible 
to degradation at high temperatures and to the proteo 
lytic action of the cultured cells themselves. Addition 
ally, peptides adsorbed to a surface are subject to de 
sorption upon repeated use. Thus, surfaces with long 
amino acid residue peptides absorbed thereto have been 
found to be unstable and thus unsuitable in preparing 
reusable cell culture substrates. 
An alternative approach in promoting cell adhesion is 
through chemical modification of the surface to facili 
tate the attachment of peptides to the substrate. How 
ever, present technology for chemical modification of 
substrates is particularly non-specific and empirical. For 
example, treatment of polymer surfaces with various 
radio frequency plasma discharges, both polymerizing 
and nonpolymerizing, has been proposed. Alternative 
approaches of surface acid treatment or surface incor 
poration of charged groups have also been described. 
However, these various surface treatments alter only 
the pattern of protein adsorption on the culture surface, 
which in turn functions to modify the cells' characteris 
tic adhesion and spreading behavior. Thus, the protein 
and peptide surface adsorption and desorption problems 
still remain, limiting the reusability of culture plates and 
other surfaces so treated. 
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An alternative to surface adsorption of peptides to 
promote cell adhesion has been to instead chemically 
attach peptides to a surface. For example, the method of 
polymer surface chemical modification was employed 
by Brandley, et al., (1988) (Analyt. Biochem, 172: 270), 
who proposed the inclusion of a 9-mer peptide in a 
polymer substrate to promote cell adhesion (Id.). While 
enhanced cell adhesion was attained using the Brandley 
technique, the method required higher concentrations 
of peptide to promote the same level of cell adhesion 
observed in the relatively more peptide efficient ad 
sorbed peptide systems. For example, FIG. of Brand 
ley shows surface concentrations of peptide on the aver 
age of about 6 nanomoles per square centimeter (Brand 
ley, at pg. 275). These high peptide concentrations sug 
gest the Brandley method does not control for the inclu 
sion of peptide at the polymer surface only, but instead 
permits the incorporation of peptide throughout the 
bulk of the polymer. Given that synthetic peptides cost 
about $5,000 per gram, this method would not facilitate 
the economical preparation of cell culture substrates 
commercially. 
Thus, a need still exists in the art for an economical 
system of preparing thermally stable, peptide-coated 
surfaces with cell adhesion promoting characteristics 
which are resistant to the desorptive effects of repeated 
usage and proteolysis by cellular proteases or proteases 
added to remove cells. A more commercially feasible 
and economical system would be substantially more 
peptide-efficient than those proposed by Brandley and 
others of skill in the art of cell culture and polymer 
chemistry. 
The following abbreviations are used by Applicants 
throughout the application: 
D = Asp (aspartic acid) 
F=phenylalanine 
G = Gly (glycine) 
I=Ile (isoleucine) 
R = Arg (arginine) 
S=Ser (serine) 
Y=Tyr (tyrosine) 
CFN = cellular fibronectins 
FC=focal contacts 
FEP=fluorinated ethylene polymers 
fgs fibrinogen 
GREDV = glycine, arginine, glutamic acid, aspartic 
acid, valine or Gly-Arg-Glu-Asp-Val 
GRGD = amino acid sequence glycine, arginine, gly 
cine, aspartic acid; or Gly-Arg-Gly-Asp 
HFF =human foreskin fibroblast cells 
kD=kilodalton 
mer=amino acid residue 
nm - nanomoles 
PAE = porcine aortic endothelial (cells) 
PBS = phosphate buffered saline 
PDMS=poly(dimethyl siloxane) 
PET = poly(ethylene terephthalate) 
pFN = plasma fibronectins 
PHEMA = poly(hydroxyethyl methacrylate) 
PTFE=poly(tetrafluoroethylene) 
REDV=arginine, glutamic acid, aspartic acid, valine 
or Arg-Glu-Asp-Val 
RGD = amino acid sequence arginine, glycine, aspar 
tic acid, or Gly-Arg-Gly-Asp 















YIGSR = tyrosine, isoleucine, glycinem serine, aspar 
tic acid or Try-Ile-Gly-Ser-Arg 
SUMMARY OF THE INVENTION 
The present invention features a new process by 
which surfaces may be modified to yield proteolytically 
stable, reusable surfaces which promote the amount of 
and enhance the rate of receptor mediated cell adhe 
sion. The specifically directed and controlled chemical 
processes herein disclosed provide for the chemical 
attachment of peptides at the surface of a flask or other 
device without diffusion of the peptide throughout the 
bulk of the material treated. Thus, the disclosed meth 
ods provide a surprisingly enhanced cell adhesion pro 
moting surface with the use of only a fraction of the 
peptide required by formerly proposed methods. The 
peptides are chemically attached to a surface, and thus 
avoid the desorbtion problems which plagued surface 
peptide-adsorbed systems of the past. These advantages 
are accomplished through the chemical attachment of 
small peptides, for example, those having less than 12 
amino acid residues, at only the surface of the substrate. 
An additional feature of the present invention lies in 
that the process provides for the use of cell adhesion 
molecule fragments, rather than whole surface adhesion 
molecule (SAM) proteins. The acronyms SAM and 
CAM are used interchangably to denote surface, sub 
strate or cell adhesion molecules that are proteins which 
interact with extracellular matrix components through 
a specific binding domain to promote specific domain 
mediated adhesion of cell receptors (i.e., the cells). 
SAMs are a family of proteins that include fibronectin, 
vibronectin, thrombospondin, laminin, and other prote 
ins. Grafting of small peptide fragments provides a 
further advantage in that surfaces so treated are less 
subject to denaturation and proteolytic degradation 
than surfaces grafted with whole proteins or larger 
peptides. 
A further feature of the present invention is that it 
provides a more efficient surface modification system. 
For example, Applicants are able to produce a deriva 
tized surface with maximal cell adhesion properties 
using only 1/500th the amount of peptide of formally 
proposed chemical grafting methods. For example, 
Brandley, et al. employed a method which yielded on 
the average of 6 nanomoles/cm2 (6,000 picomoles/cm2) 
peptide surface concentration (Brandley, et al., pg. 274, 
Table 1). In contrast, Applicants have demonstrated 
enhancement of cell adhesion with a surface peptide 
concentration of as little as 0.0012 picomoles/cm2 (a 
five million fold improvement). Applicants were able to 
omit a significant amount of the surface peptide in the 
process of chemically binding a peptide to a surface, 
and were able to achieve such without a loss in cell 
adhesive promoting activity. 
An additional feature of the disclosed surface modifi 
cation techniques is that they provide a novel approach 
for promoting receptor-mediated cell attachment inde 
pendent of adsorbed serum components. The present 
invention provides a method for the treatment of sur 
faces which is effective in promoting the adhesion of 
any species and type of cell, including for example, 
porcine, murine and human cells. Types of cells which 
have already been successfully cultured on the treated 
surfaces include aortic, foreskin and 3T3 fibroblast cells 
(ATCC #CRL1658). 
The present invention also features adaptability of use 
with a wide variety of small peptides. While numerous 
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small peptide may be used in conjunction with the pres 
ent invention, the most preferred small peptides include 
those with less than 12 amino acid residues (12 mer). 
More preferably, these peptides contain between 3-9 
amino acid residues (3-9 mer). The most preferred pep 
tides have either 6 amino acid residues (6 mer) or 4 
amino acid residues (4 mer). The number of amino acid 
residues in a peptide are are often denoted herein by 
such nomenclature (e.g., 6 mer, 4 mer, etc.). 
These small peptides are further described as includ 
ing a minimal cell-surface receptor recognition se 
quence, for example, RGD, YIGSR, or REDV. This 
sequence permits the cell receptor mediated support of 
cells to a treated surface. By way of example, the most 
preferred peptides which include the about minimal cell 
surface receptor recognition sequences include the 
GRGD (Gly-Arg-Gly-Asp), GYIGSRY (Gly-Tyr-Ile 
Gly-Ser-Arg-Tyr), GYIGSR (Gly-Tyr-Ile-Gly-Ser 
Arg), GRGDY (Gly-Arg-Gly-Asp-Tyr), YIGSR (Tyr 
Ile-Gly-Ser-Arg), RGD (Gly-Arg-Asp), REDV (Arg 
Glu-Asp-Val), GREDV (Gly-Arg-Glu-Asp, Val), 
RGDS (Arg-Gly-Asp-Ser), GRGDS (Gly-Arg-Gly 
Asp-Ser), RGDF (Arg-Gly-Asp-Phe), GRGDF (Gly 
Arg-Gly-Asp-Phe) amino acid sequences. These frag 
ments contain either the cell attachment sequence of 
many surface adhesion molecules (RGD) or the cell 
attachment sequence of laminin (YIGSR), a particular 
surface adhesion protein, or the cell adhesion molecule 
fibronectin (REDV). These most preferred peptides 
may further include a C-terminal Y for radioiodination. 
The N-terminal G is used as a spacer with the particular 
peptide between the adhesive peptide and the surface. 
The small peptides are used to provide cell receptor 
recognition sites required for cell adhesion on the 
treated surface. 
While any surface concentration of peptides of at 
least 1 picomole/cm2 is expected to be sufficient to 
enhance the cell adhesive characteristics of a surface, a 
more preferred range of peptide surface concentration 
is between about 0.5 to 100 picomoles/cm2. A more 
preferred range of peptide surface concentration is 0.5 
to 20 picomoles/cm2. The most preferred peptide sur 
face concentration of the present invention is about 12 picomoles/cm2. 
Conventional methodologies rely upon direct adsorp 
tion of the CAM or the peptide to the surface, or ad 
sorption of non-CAM proteins followed by cross-link 
ing of the peptides to the adsorbed proteins, thus allow 
ing for desorption of these components into the culture 
media. The present invention provides the further ad 
vantage of avoiding this problem of protein desorption 
by chemically bonding the peptide through covalent 
bonds to hydroxyl or other reactive moieties of the 
desired substrate. 
There are many situations in the use of biomedical 
implants where it is desirable that the surrounding cells 
in the tissues adhere to and spread upon (integrate with) 
the implant surface. The present invention provides a 
method for surface modification to obtain such desired 
implant integration within the host. The present inven 
tion further features a method for reducing the inci 
dence of infection attendant to the in vivo implant of 
biomedical devices. A major risk associated with im 
plantation of biomedical devices has been infection. The 
lack of a continuous protective layer between the de 
vice and the biological tissue opportunizes the entry of 
bacteria and other infectious agents into the tissue. With 













the device, such undesirous side effects will be mini 
mized, as a continuous protective cell covering is pro 
vided, closing the potential entry of infectious agents. 
Additionally, the long-term stability of the disclosed 
treated surface method makes the system ideal in pre 
paring various biomedical implants for extended term 
body emplacement. For example, in use with nerve 
growth guides and indwelling catheters. The surface 
modification system of the present invention also pro 
vides new avenues for mammalian cell bioreactor de 
sign, since it provides a stable integral surface compo 
nent which supports cell adhesion independent of media 
CAMs. Such substrates provide the further advantage 
of permitting the use of serum-free media which are 
deficient in cell adhesion molecules. 
The chemistry of the present invention is directly 
applicable to any material with surface hydroxyl moi 
eties or other surface reactive groups to which such 
moieties can be added. Most other surface treatments to 
enhance cell adhesion do so by the enhancement of 
protein absorption. The peptide grafting approach of 
the present invention eliminates the requirement for 
absorbed proteins completely, as the cell has receptors 
for the surface-coupled synthetic peptides. These cova 
lently bound minimal sequences are much more stable 
to cellular proteolysis and thermal degradation than 
adsorbed cell adhesion proteins or adsorbed proteins 
conjugated with adhesion peptides, since desorption is 
eliminated and the active groups (e.g. RGD, YIGSR or 
REDV sequence) are not as exposed to soluble pro 
teases. 
While a variety of chemical methods exist by which 
the present surfaces may be prepared, the various ap 
proaches fall into the general class of surface activation, 
via modification of a nucleophile, such as an amine or 
hydroxyl, followed by coupling to the peptides, via 
another nucleophile such as an amine or hydroxyl (23). 
By way of example, the activation of surface hydroxyl 
groups may be accomplished through treatment with 
agents such as tresyl chloride, glutaraldehyde, cyanuric 
chloride, sulfonyl chlorides, cyanogen bromide and 
benzoin dimethyl sulfoxide with potassium tert-butox 
ide in dimethylsulfoxide. Treatment with these particu 
lar surface activators is followed by a procedure by 
which a peptide is covalently linked to the hydroxyl 
group. Additionally, the present invention may be prac 
ticed through the production of active carboxyl groups 
on the surface by using, for example, succinic anhy 
dride. The exposed surface is then rinsed and coupled 
with peptide. 
By way of example, biomedical implants which 
would benefit from the inclusion of the present surface 
peptide treatment include penile, heart, vaginal, and hip 
implants; catheters; artificial veins or arteries, artificial 
tendons and, ligaments; artificial bone screws, bone 
plates, bone fragments and bone joints; artificial skin; 
nerve growth guides; and intraocular lenses and the 
like. By way of example, materials used as cell and 
tissue culture substrates which profit from the present 
surface peptide treatment include tissue culture flasks, 
petri dishes, microcarrier beads, porous macrocarriers, 
fibers, hollow fibers, monolith supports, and roller bot 
tles. 
The disclosed methods may be used in the derivatiza 
tion of any surface to which enhanced cell adhesion is 
desired. By way of example and not limitation, these 
surfaces include metal, ceramic or polymer surfaces. A 
preferred embodiment of the invention is directed to the 
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derivatization of polymer surfaces. While any polymer 
surface may be derivatized using the proposed methods, 
particular exemplary, polymer surfaces most preferably 
include poly(hydroxyethyl methacrylate) (PHEMA), 
poly(ethylene terephthalate) (PET), poly(tetrafluoro 
ethylene) (PTFE), fluorinated ethylene (FEP), poly(- 
dimethyl siloxane) (PDMS) and other silicone rubber 
surfaces. PET, otherwise known as Dacron, is a polyes 
ter frequently used for biomedical implants. PTFE is 
otherwise known as Teflon. Most preferred polymeric 
matrix of the present invention comprises poly(hydrox 
yethyl methacrylate) (PHEMA). 
The PHEMA polymeric matrix comprises a gel-like 
matrix having about a 45% water composition, and was, 
prior to the disclosure of the present invention, unable 
to support cell adhesion. 
Use of peptides in conjunction with other high-water 
polyacrylamide gel matrixes is much less peptide-effi 
cient compared to such use with polymers of lower 
water content. Highly hydrated gels are highly permea 
ble to peptides and thus facilitates the substantial and 
indiscriminant diffusion of small peptides into the bulk 
of the polymer. These highly hydrated polymers have 
been used for protein electrophoresis, demonstrating 
that they are even permeable to whole proteins, which 
are very large molecules (21), Polymer gels comprising 
polyacrylamide include about 90% water, and, thus 
would be unsuitable in the practice of the present inven 
tion. 
Another most preferred embodiment of the invention 
is directed to the derivitization of a particular ceramic, 
glycophase glass (glycerol propylsilane bonded glass). 
By way of example, a most preferred metal to be used 
with the lo described process is titanium. 
The present invention also includes methods of en 
hancing cell adhesion to a surface comprising first acti 
vating the surface, coupling a peptide to the activated 
surface, and then plating mammalian cells on the pep 
tide derivatized surface, wherein the preferred peptide 
is smaller than a 12 mer. The process whereby the pep 
tide is coupled to any activated surface most preferably 
comprises exposing an activated surface to a solution 
containing a sufficient amount of the peptides described 
above (having cell-adhesive characteristics). While any 
concentration of peptide solution of at least about 10 
ng/ml would produce equal results in the present 
coupling process, solutions between about 10 ng/ml 
peptide and 100 ug/ml peptide are also suitable. Most 
preferably, the process includes a peptide solution hav 
ing a concentration of 10 ng/ml peptide. In one pre 
ferred embodiment of the invention, the peptide of the 
peptide solution includes the amino acid sequence argi 
nine-glycine-asparagine (RGD). In another preferred 
embodiment of the invention, the peptide of the peptide 
solution includes YIGSR. In still another preferred 
embodiment of the invention, the peptide of the peptide 
solution includes REDV or RGDF. A most preferred 
peptide to be used in the method of the present inven 
tion comprises a peptide sequence selected from the 
group consisting of GRGD, RGDY, GRGDY, 
GYIGSR, GYIGSRY, YIGSR, RGDS, REDV, 
GREDV, RGDF and GRGDF. These peptides are 
most preferably used in the derivatization of polymer 
surfaces, such as PET polymer and PHEMA polymer, 
or glass surfaces, such as glycophase glass. However, 
any peptide which includes an amino acid surface capa 
ble of supporting cell receptor recognition may be used 













Applications of the bioactive cell adhesive peptide 
grafting approach to enhance cell adhesion include the 
following uses: 
1. For laboratory scale tissue and cell culture of anchor 
age dependent cells and cell lines. This approach may 
be useful in the treatment of laboratory glassware and 
plasticware used as cell culture substrates, such as 
tissue-culture flasks and Petri dishes. It would be 
useful for animal, insect, and plant cells and tissues, as 
all utilize essentially the same molecular biology for 
adhesion. 
2. For large scale tissue and cell culture. The approach 
may be useful in the treatment of microcarriers, po 
rous macrocarriers, hollow fibers, monolith supports, 
and roller bottles. 
3. For the interior of implantable artificial vascular 
grafts to promote the endothelialization of these sur 
faces. 
4. For the exterior and anastamotic regions (ends) of 
vascular grafts to promote integration into the tissues. 
5. For other implantable devices where integration with 
the tissues is desirable, such as artificial tendons, liga 
ments, bone screws and plates, bone fragments, joints, 
and skin. 
6. For the treatment of sutures to promote adhesion 
with and integration to the tissues. 
7. For the promotion of directional growth or migration 
of cells or tissues, this approach may be useful when 
the peptides are grafted to the surface with a gradient 
of surface concentration. An example where this may 
be useful is in nerve growth guides for peripheral 
nerve regeneration. 
8. For use in research. The present systems allow for the 
study of cell adhesion in the presence of serum with 
out the confusion of the effects of protein adsorption. 
Thus, background levels in the test system remain 
low. Additionally, the present methods control for 
the amount of peptide which gets coupled to a sur 
face, which is also important in studying cell adhe 
SO. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows the hydroxymethylation of PET films 
via electrophilic aromatic substitution. The reaction 
was carried out at room temperature with 18.5% form 
aldehyde (v/v) and 1M acetic acid. 
FIG. 2 shows the tresyl activation and GRGD cou 
pling to hydroxymethylated PET films. All reactions 
were performed at room temperature. 
FIGS. 3a and 3b show adherent and spread 3T3 fibro 
blasts on (a) GRGD coupled and (b) untreated PET 
films. Arrows indicate individual cells that were scored 
as spread cells. (200x Hoffman illumination). 
FIG. 4 shows the spreading of 3T3 fibroblasts on 
GRGD coupled and untreated PHEMA films in a 
serum-free culture medium. Extent of cell spreading 
was determined 3 hours after seeding of the substrates. 
FIG. 5 shows a comparison of 3T3 spreading on 
GRGD coupled PET (solid curve, open boxes) versus 
GRGD adsorbed to PET (hatched curve, solid 
diamonds) and untreated PET (dot-hatched curve, open 
boxes). 
FIG. 6 shows the amount of 3T3 spreading on the 
modified (solid bars) and unmodified (hatched bars) 
films in a serum-free and complete medium. The extent 
of cell spreading was determined 2 hours after inocula 




FIG.7 shows the effects of soluble RGDS on spread 
ing 3T3 cells on the GRGD derivatized PET films in 
serum-free culture medium. Cells were preincubated for 
30 minutes with RGDS prior to inoculation of the films. 
The extent of cell attachment was determined 3 hours 
after inoculation. Cells preincubated with RGDS 
(hatched bar). Untreated control cells (solid bar). 
FIG. 8 shows the growth kinetics of 3T3 cells on 
GRGD derivatized (open squares) and untreated (solid 
diamonds) PET surfaces. These studies were performed 
in complete medium. 
FIG. 9 shows surface concentration of GRGDY-125 
grafted to glycophase glass was added to coupling 
buffer (0.2M sodium bicarbonate pH 10) and incubated 
on tresyl activated glass at room temperature. Input 
concentrations were soluble peptide available for reac 
tion per unit area of glass surface. Surface concentration 
is defined as the moles of peptide coupled per unit area 
of glass and were washed glass samples in a gamma 
counter and calculating the values based of the labeled 
peptide. Each point is the average of triplicate determi 
nations surface concentration was 12.1 pmol/cm2. 
FIGS. 10A, 10B, 10C and 10D show cumulative 
histograms showing the cell areas of HFFs on glyco 
phase glass with GRGDY. Cells were suspended in 
either complete medium (A) containing albumin (C), 
(D), and inoculated on the substrates. A and C represent 
data collected on the RGD-derivatized glass, whereas 
(B) and (D) represent nonadhesive control surfaces. 
The areas of individual cells were video microscopy 
coupled with digital image processing. Cell spreading 
observed on the peptide-grafted surfaces, even in the 
absence of serum; there was no cell spreading on the 
ungrafted surfaces even with serum, and most of these 
cells were nonadherent. At least 100 cells were ana 
lyzed at each time point to generate the cumulative 
data. Lines: (-) 5 minutes; (......) 30 min.; (-----) 60 min.; 
and (------) 120 min. Midpoint with 50% above and 50% 
below for the various time points (in order): A: 15 min. 
265um2; 30 min.906 um2; 60 min., 1113 um2; 120 min., 
2130 um2; B: 385,397, 448, 453; C: 248, 950, 864, 1207; 
D: 377, 325,388, 388. 
FIG. 11 shows growth of HFFs on GRGDY-deriva 
tized glycophase glass (open squares) and untreated 
borosilicate glass (solid squares) in DMEM supple 
mented with 10% fetal calf serum. Cells were visualized 
with 100x phase contrast microscopy. The number of 
cells per unit area of growth surface was calculated 
based on an averaged cell count per area of field from a 
sample size of 10 fields per time point. The similar 
growth rates indicate that cells are able to round-up 
from the peptide-grafted surfaces and to subsequently 
divide. 
FIGS. 12A, 12B, 12C and 12D show cumulative 
histograms showing the cell areas of HFFs on glyco 
phase glass derivatized with GYIGSRY. Cells were 
suspended in either complete medium (A), (B), or 
serum-free medium containing albumin (C), (D), and 
inoculated on the substrates. (A) and (C) represent data 
collected on the YIGSR-derivatized glass, whereas (B) 
and (D) represent data collected on the nonadhesive 
control surfaces. The areas of individual cells were 
determined by phase contrast video microscopy cou 
pled with digital image processing (12). Cell spreading 
was observed on the peptide-grafted surfaces, even in 
the absence of serum; there was no cell spreading on the 
ungrafted surfaces even with serum, and most of these 











lyzed at each time point to generate the cumulative 
data.) Lines: (solid line) 0 hours; (dotted line) 3 hours; 
(heavy dashed) 6 hours; and (light dashed) 9 hours). 
Midpoint cell area, with 50% of the cells above and 
50% below for the various time points (in order): A: 0 
hours; 505 um2; 3 hours, 2200 um; 6 hours, 2333 um2; 9 
hours, 3375 um2; B: 340, 520, 486, 517; C: 517, 1045, 
1033, 1400; D: 245, 306, 362, 514. 
FIGS. 13A, 13B, 13C and 13D show phase contrast 
(13 A, C) and IRM (13 B, D) micrographs of spread 
HFFs on RGD-grafted glass. Cells were incubated for 
4 hours in serum-free (13 A, B) or complete medium (13 
C, D). Scale bar = 10 um. 
FIGS. 14A, 14B, 14C and 14D show phase contras 
(14A, C) and IRM (14 B, D) micrographs of spread 
HFFs on YIGSR-grafted glass. Cells were incubated 
for 8 hours in serum-free (14A, B) or complete medium 
(14 C, D). Scale bar = 10 um. 
FIGS. 15A, 15B, 15C and 15D show fluorescent 
micrographs of HFFs stained for F-actin. HFFs were 
incubated for 4 hours on RGD-derivatized substrates in 
serum-free (15 A) and complete (15 B) medium. 15 C 
and 15 D are spread cells on YIGSR-derivatized sub 
strated after an 8 hour incubation in serum-free (C) and 
complete (D) medium. Scale bar = 10 um. 
Flo.16 shows the effect of the absence or presence of 
serum on porcine aortic endothelial cell spreading in 
cell cultures established on either PET or GRGD pep 
tide derivatized PET surfaces. 
FIG. 17 shows the rate of cell spreading observed on 
peptide derivatized PET (polymer) surfaces versus non 
treated PET (polymer) surfaces. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
The present invention is directed toward treated sur 
faces and methods of preparing treated surfaces which 
enhance cell-surface adhesion thereto independent of 
adsorbed peptides and soluble media components. This 
methodology provides techniques for preparing various 
types of substrates which simplify optimization of cul 
ture systems and which also improve the amount and 
rate of cell bioadhesion to surfaces of various materials. 
More particularly, the surface modification tech 
niques provide for the chemical grafting of peptides to 
a surface, the peptide comprising at least the minimal 
amino acid sequence included in a cell (surface) adhe 
sion molecule, such as RGD in fibronectin, or YIGSR 
in laminin, REDV in some forms offibronectin, or some 
other short peptide sequence related to or derived from 
the sequence of a protein involved in cell-surface or 
cell-cell adhesion. The terms "Cell Adhesion Molecule' 
(CAM), "Surface Adhesion Molecule' (SAM) and 
"Substrate Adhesion Molecule' (SAM) are used inter 
changeably in describing the family of proteins and 
peptides found to facilitate cell receptor-mediated adhe 
sion or attachment to a surface. 
The present surface treatment methods basically 
comprise chemically activating a surface to expose re 
active groups, rinsing the activated surface, and then 
exposing the surface to a solution containing small pep 
tides, for example, a peptide which includes the RGD, 
YIGSR, REDV, or other amino acid sequence which 
facilitates receptor mediated cell attachment having less 
than a total of 12 amino acid residues (12-mer). A cova 
lent chemical bond attaches the terminal end of the 
peptide to a reactive moiety on the surface being 
treated. A variety of chemical methods exist by which a 
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surface may be activated to expose reactive groups. One 
of these methods is by way of the tresyl activation. 
Other alternative chemistries which may be used in the 
practice of the present invention, by way of example 
include: 
(1) Activation of the surface with glutaraldehyde: At 
temperatures between 0° C. and 80' C., treat the surface 
with an aqueous solution of 5% to 37% glutaraldehyde 
for about one hour. The glutaraldehyde will couple 
with any exposed nucleophilic groups, such as amines 
and hydroxyls. Rinse the surface with water, and treat 
the surface with a solution of peptide, between 10 ng/ml 
and 1 mg/ml. Any nucleophilic groups on the peptide, 
such as thiols, amines, and hydroxyls, will be coupled to 
the surface-coupled glutaraldehyde function. 
(2) Activation of the surface with cyanuric chloride: 
At temperatures between 0° C. and 80 C., treat the 
surface with a nonaqueous solution of about 5% cyanu 
ric chloride for about one hour. The cyanuric chloride 
will couple with any exposed nucleophilic groups, such 
as amines and hydroxyls. Rinse the surface with dry 
solvent, and treat the surface with a solution of peptide, 
between 10 ng/ml and 1 mg/ml in a nonaqueous sol 
vent, such as acetonitrile. Any nucleophilic groups on 
the peptide, such as thiols, amines, and hydroxyls, will 
be coupled to the surface-coupled cyanuric chloride 
function. 
(3) Activation of the surface with other sulfonyl chlo 
rides: Follow the procedure outlines in Example 3 using 
another member of the sulfonyl chloride family, such as 
tosyl chloride. 
(4) Activation of the surface with cyanogen bromide: 
At temperatures about 20° C. or below, expose the 
surface to an aqueous solution of cyanogen bromide at 
pH 10-11 for about one hour. The cyanogen bormide 
will covalently couple and activate surface hydroxyl 
groups. Rinse the surface with water at pH 10-11, and 
couple with peptide between 10 ng/ml and 1 mg/ml in 
this same solution for about 1 hour. The peptide will 
couple to the cyanogen bormide groups via any amine 
functions on the peptide. 
(5) Activation of the surface to produce active carbo 
nyl-bearing esters, e.g. with succinic anhydride: At 
temperatures of about 20° C., expose the surface to a 
solution of succinic anhydride, whereupon that com 
pound will react with surface hydroxyls and amine to 
produce esters and amides, respectively. Rinse the sur 
face and couple with peptide between 10 ng/ml and 1 
mg/ml for about 1 hour. The peptide will react with the 
activated surface via amine or hydroxyl groups. 
(6) Preactivating a polymer by adding hydroxyls 
with benzoin dimethyl sulfoxide: Hydroxyl functions 
are added to poly(tetrafluoroethylene) (PTFE). As 
described by Costello and McCarthy, Surface-Selective 
Introduction of Specific Functionalities onto Poly(tet 
rafluoreoethylene), Macromolecules 20:2819-2828 
(1987)). Benzoin dimethyl sulfoxide is added to a solu 
tion of potassium tert-butoxide in dimethyl sulfoxide 
and placed in contact with the PTFE surface. The reac 
tion is allowed to proceed at 50° C. for 1 hour. The 
material is removed and rinsed with tetrahydrofuran 
(THF). This intermediate surface is then treated with 
1M borane in THF at room temperature for 12 hours. 
The surface is then treated with 1M NaOH containing 
10% hydrogen peroxide at 0° C. for 3 hours, after 
which it is washed sequentially with dilute NaOH, wa 
ter, dilute HCl, water, THF, and heptane. This pro 














quently be activated by any of the chemistries described 
above. 
The most preferred method by which peptides are 
attached to a surface comprises surface activation of the 
surface, by a tresyl immobilization method, as described 
by Nilsson and Mosbach (1981) (Biochem. Biophys. Res. 
Commun., 102:449-457). Specifically, tresyl activation 
is a process wherein the surface is first immersed in 20 
ml. dry ether containing about 40 ul 2,2,2-trifluoroe 
thanesulfonyl chloride (tresyl chloride) and about 2 ml. 
triethylamine for about 15 minutes at room temperature. 
These activated surfaces were then rinsed with 0.2M 
sodium bicarbonate pH 10 buffer. The surfaces were 
then placed in the same buffer containing about 60-100 
ng/ml of the peptide for about 20 hours at room temper 
ature. Most preferably, the concentration of peptide 
solution is about 10 ng/ml. This incubation time allows 
for the coupling of the peptide to the surface hydroxyl 
groups. This particular embodiment of the invention is 
preferably used with the GRGD peptide. 
The peptides couple to an activated surface most 
preferably by exposing the activated surface to a solu 
tion containing an appropriate amount of the desired 
peptide. While any concentration of peptide solution of 
at least about 10 ng/ml would produce equally satisfac 
tory results, solutions containing between about 10 
ng/ml peptide and 100 ug/ml peptide are preferred. 
Most preferably, a peptide solution of about 10 ng/ml 
peptide is used in the coupling process. 
The treated surfaces produced by the disclosed meth 
ods are characterized by a peptide surface concentra 
tion of at least 1 picomole/cm2. It is expected peptide 
surface concentrations of at least 1 picomole/cm2 are 
sufficient to enhance the cell adhesive characteristics of 
a surface. A more preferred range of peptide surface 
concentration is between about 0.5 to 100 picomo 
les/cm2. A most preferred range of peptide surface 
concentration is between about 0.5 to 20 picomo 
les/cm2. The most preferred surface peptide concentra 
tion is about 12 picomoles/cm2. 
Where no surface hydroxyl moieties exist on the 
surface to be treated, the surface was pretreated. This 
pretreatment preferably comprised a surface hydroxyl 
ation procedure wherein an electrophilic aromatic sub 
stitution was employed to add hydroxyalkyl groups to a 
surface. A particularly preferred method of this pre 
treatment comprises immersing a surface in an about 
18.5% (v/v) solution of formaldehyde and about 1M 
acetic acid for about 4 hours at room temperature. This 
procedure was used in the hydroxymethylation of a 
particularly preferred embodiment of the invention 
comprising a PET polymer surface. The hydroxylated 
surface was then tresyl activated with the attachment of 
peptides thereto as described above. Most preferably, 
the pretreatment method disclosed herein is used to 
prepare polymer surfaces, particularly PET polymer 
surfaces, With GRGD or GYIGSR peptides. Various 
other surface hydroxylations would be equally as useful 
for use in conjunction with other polymers or materials. 
Various other linking characteristics may also be used, 
where the N-terminal amine or another reactive group 
on the peptide is reacted with a group on the surface, 
perhaps with the use of some linker. 
Any surface may be used in the practice of the pres 
ent invention. By way of example, surfaces particularly 
suitable for use in the practice of the present invention 
comprise a ceramic, a metal, or a polymer surface. Most 
preferably, the present invention is used in the treatment 
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of polymer surfaces and ceramic (glass) surfaces. By 
way of example, the polymer surfaces comprise poly(- 
hydroxyethyl methacrylate) (PHEMA), poly(ethylene 
terephthalate) (PET), poly(tetrafluorethylene) (TPFE), 
fluorinated ethylene (FEP), poly(dimethyl siloxane) 
(PDMS) and other silicone rubbers. While a variety of 
glass surfaces may be treated with the proposed meth 
ods, the glass surface most preferred comprises glycerol 
propylsilane bonded glass (glycophase glass). 
A minimal amino acid sequence included in many cell 
adhesion molecules is RGD (arginine-glycine-aspartic 
acid amino acid sequence), or YIGSR (tyrosine-isoleu 
cine-glycine-serine-arginine) or REDV (arginine 
glutamic acid-aspartic acid-valine). While any peptide 
containing a minimal amino acid sequence active in cell 
adhesion may be used in the practice of the present 
invention, those sequences most preferred comprise 
RGD, YIGSR, GRGD, GYIGSR, GRGDY, 
GYIGSRY, RGDY, YIGSRY, REDV, GREDV, 
RGDF and GRGDF. 
In a particularly preferred embodiment of the present 
invention, the peptides GRGDY and GYIGSRY are 
chemically grafted to a surface of glycerol propylsilane 
bonded glass (glycophase glass) a specific type of ce 
ramic. The C-terminal Y of these preferred peptides is 
included for radio iodination, the N-terminal G (gly 
cine) is provided for use as a spacer with the particular 
peptide between the adhesive peptide and the surface. 
The small peptides are used to provide cell receptor 
recognition sites required for cell adhesion on the 
treated surface. 
In another particularly preferred embodiment of the 
present invention, the GRGD and GYIGSR peptides 
are used in the chemical derivatization of polymer sur 
faces. A most preferred embodiment of the present 
invention comprises a PHEMA or PET polymer sur 
face derivatized with GRGD or GYIGSRY peptides. 
Another even more most preferred embodiment of the 
present invention comprises a PHEMA or PET poly 
mer surface derivatized with GYIGSRY peptides. 
A surface so treated to include covalently bound 
peptide provides mammalian cell receptor recognition 
sites which allow the cells to anchor to the substrate and 
grow independent of media serum content and surface 
adsorbed proteins. Thus, the present invention discloses 
methods which provide for receptor-mediated cell ad 
hesion in the absence of any intermediate adsorbed 
protein, i.e., an entirely self sufficient cell adhesion and 
spreading supportive surface. 
While any peptide fragment which includes the mini 
mal amino acid sequence of the cell adhesion molecule 
may be used in the practice of the present invention, 
peptide fragments containing less than 12 amino acid 
residues (mer) are preferred. Peptide fragments having 
between about 3-9 amino acid residues are even more 
preferred. The most preferred peptides include either 4 
or 6 amino acid residues. The length of the peptide 
fragment will affect the susceptibility of the peptide to 
degradation, and therefore, the shorter the fragment, 
the less peptide surface degradation would be expected. 
The present invention further includes surface 
treated biomedical implant devices and methods for 
preparing the same. Devices having such surface treat 
ments enhance the amount and rate of cell adhesion, and 
thus the rate of tissue integration of the device in vivo. 
Enhanced cell adhesion and tissue integration act to 
minimize infection, as potential tissue ports of entry are 













Any device surface to which the described peptides 
may be chemically grafted can be treated with the de 
scribed methods. By way of example, these device sur 
faces include those of penile, vaginal, heart and hip 
implants or replacements; catheters; artificial skin, veins 
and arteries; artificial tendons and ligaments; artificial 
bone screws, plates, fragments and joints; nerve growth 
guides; intraocular lenses and the like. 
Applicants' present evidentiary material herein 
which demonstrate the cell adhesive properties im 
parted to a surface treated with the disclosed peptides 
and methods of the present invention. The treated sur 
faces are suitable for the culture of any species and type 
of cell including, for example, porcine, murine, insect 
and human cells. Applicants have used a variety of cells 
in demonstrating the present invention, including, by 
way of example and not limitation, foreskin fibroblast 
(HFF) cells, aortic endothelial (PAE) cells, embryotic 
and newborn tissue cells. However, the present inven 
tion may be used in conjunction with any species or 
tissue source of cell, and is not limited to use with any 
one particular type of cell. The following paragraphs 
outline the most preferred methods of culturing particu 
lar cell types used to demonstrate the present invention. 
CELL CULTURE PROCEDURES 
3T3 Cells 
NIH/3T3 cells, an immortal cell line of embryotic 
cells established from Swiss mouse embryos, were ob 
tained from the American Type Culture Collection cell 
repository (ATCC #CRL 1658), Cultures were main 
tained in Dulbecco's modified Eagle's medium supple 
mented with 10% fetal calf serum and incubated at 37 
C. in a humidified 5% CO2 atmosphere. Confluent mon 
olayers of cells were harvested by incubation in a solu 
tion of 0.5% trypsin and 0.53 mM EDTA in phosphate 
buffered saline (PBS) at 37 C. for 15 minutes. Cells 
were resuspended in fresh medium and subcultivated by 
allowing cells to attach and grow to in new culture 
dishes. 
Human Foreskin Fibroblasts 
Human foreskin fibroblasts (HFFs) are primary cell 
lines that are isolated from neonatal foreskin tissue from 
Seton Hospital, neonatal ward, Austin, Tex. About 5-10 
newborn foreskins are collected aseptically in sterile 
PBS, minced into 5 mm2 pieces, and incubated in tryp 
sin-EDTA for 4 hours. HFFs were collected by centrif 
ugation at 200 g for 5 minutes and resuspended in Dul 
becco's modification of Eagle's medium (DMEM, 
Mediatech) supplemented with 10% fetal calf serum 
(GIBCO), 400 u/ml penicillin (Irvine) and 400 ug/ml 
streptomycin (Irvine) and incubated at 37 C. in a hu 
midified 5% CO2 atmosphere. Cells were subcultivated 
by trypsinizing confluent monolayers, suspending cells 
in fresh medium, and seeding cells into new flasks. 
HFFs were maintained in culture for up to 20 passages 
before they are discarded. 
Porcine Aortic Endothelial Cells 
Porcine endothelial cells were obtained from sacri 
ficed miniature swine. The endothelial cells were iso 
lated by the method of Jaffe, et al. (1973, J. Clin. Invest, 
52: 2745-2756). Specifically, porcine aorta tissue seg 
ments from sacrificed miniature swine were rinsed with 
warm (37° C) PBS to remove blood and placed in 10 cc 
syringes. The lumen of the segments were then filled 
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with a 100 ul/ml solution of Sigma Type II collagenase. 
The tissue was then incubated for 30 min, at 37 C. The 
lumen of the aorta was then washed with PBS, and the 
cells were centrifuged at 200 g for 5 mins. and resus 
pended in Medium 199 supplemented with 20% fetal 
calf serum and antibiotic. The suspension was added to 
culture flasks and the cultures were maintained at 37 C. 
in a humidified, 5% CO2 atmosphere. 
The following examples are presented to describe 
preferred embodiments and utilities of the present in 
vention and are not meant to limit the present invention 
unless specifically indicated otherwise in the claims 
appended hereto. 
Example 1 describes the method by which particu 
larly preferred peptide fragments were synthesized, 
Example 2 describes the derivatization of a PH(MA 
polymer surface, Example 3 describes the derivatization 
of a PET polymer surface, Example 4 describes the 
preferred method of preparing a primary cell culture 
from foreskin tissue, Example 5 describes the adhesion 
of cells to a derivatized PHEMA and PET polymer 
surface. 
Examples 6, 7 and 8 describe the derivatization of a 
glass surface, the cell adhesive and supportive charac 
teristics of such a derivatized glass surfaces and the 
comparative cell supportive characteristics provided by 
various peptides to a derivatized verses non-derivatized 
glass surface. Example 9 describes the relative stability 
of a derivatized PET polymer and glycophase glass 
surface to heat and proteolysis. Example 10 presents a 
comparative study on the cell supportive characteristics 
of a pretreated verses a non-pretreated PET polymer 
surface. Examples 11 and 12 demonstrate proposed 
methods of using the described surface derivitization 
processes with a biomedical implant (Example ll-ind 
welling catheter; Example 12-nerve growth guide). 
EXAMPLES 
Example 1-Small Peptides 
This example demonstrates particularly preferred 
methods of synthesizing peptides having less than 12 
amino acid residues and including at least the amino 
acid sequence arginine-glycine-aspartic acid (RGD). 
This sequence is a particular minimal cell attachment 
sequence recognizable by cells in cell-receptor medi 
ated cell adhesion. 
The peptides used in these studies, GRGD, GRGE, 









synthesized by known procedure at the University of 50 
Texas Southwestern Medical School peptide synthesis 
laboratory. 
Example 2-Preparation of Phema Polymer Surface 
This experiment was designed to describe one partic 
ularly preferred method of preparing a polymer surface 
with small peptide fragments covalently attached 
thereto. PHEMA (poly(hydroxyethyl methacrylate)), is 
a hydrogel which has been found unable to support cell 
adhesion in its untreated state. 
The particularly preferred peptides GRGD and 
GYIGSR were grafted to the polymer surface rising the 
PHEMA surface hydroxyl groups and the terminal 
primary amine of the glycine linker arm of the peptide 
using tresyl chloride activation. The G group at the 
terminal end of each respective peptide was used to add 
distance between the surface-active peptide (GRGD) 





More particularly, the coupling method utilized acti 
vation of PHEMA surface hydroxyl moieties by tresyl 
chloride in an organic solvent for the reaction compo 
nents but a nonsolvent for the polymer. PHEMA films 
did not require pretreatment, since their surfaces are 
amply supplied with hydroxyethyl groups. The cell 
adhesive promoting activities of this modified surface 
were determined as outlined in Example 4, where in 
vitro cell adhesion and spreading assays were per 
formed. The tresyl leaving group was then displaced in 
an aqueous solvent by the terminal amine of the peptide 
GRGD or GYGSR. 
The unmodified PHEMA films were then tresyl acti 
vated in 20 ml dry ether containing 20 ul of 2,2,2-tri 
fluoroethanesulfonyl chloride (tresyl chloride) and 2 ml 
of triethylamine for 15 minutes at room temperature. 
Activated films were then rinsed with 0.2M sodium 
bicarbonate pH 10 buffer and placed in the same buffer 
containing 80 ng/ml GRGD for 20 hours at room tem 
perature to couple the peptide. 
Example 3-Preparation of Poly(Ethylene 
Terephthalate) (PET) Polymer Surface 
This experiment was designed to describe one partic 
ularly preferred method of preparing a surface devoid 
of hydroxyl moieties so as to facilitate the inclusion of 
small peptides thereto to promote cell adhesion. 
The PET surface is a polymer which is devoid of 
hydroxyl moieties, and therefore the surface must be 
pretreated before the surface is thereafter modified with 
a peptide. Specifically, the PET film surface was modi 
fied via an electrophilic aromatic substitution which 
added hydroxymethyl groups to the surface. The reac 
tion was carried out at room temperature and atmo 
spheric pressure. The films were then immersed in 
18.5% (v/v) formaldehyde and 1M acetic acid for about 
4 hours. The pretreated peTsurface Was then modified 
exactly as described for the pHEMA surface as outlined 
in Example 2. 
The following listing presents the most preferred 
method of pretreating a polymer surface, such as a PET 
matrix, which does not include hydroxyl moieties. The 
surface modification of hydroxyl moieties and attach 
ment of peptides fragments thereto was accomplished 
with the following protocol: 
1. Addition of surface hydroxymethyl moieties-to 
the PET polymer surface by performing an electro 
philic aromatic substitution of surface groups or the 
polymer surface, wherein the PET polymer is immersed 
in 18.5% (v/v) formaldehyde and 1M acetic acid for 4 
hours at room temperature. 
2. Tresyl Activation-of surface hydroxyl moieties 
wherein the pretreated PET film is immersed in 20 ml. 
dry ether containing 40 ul of 2,2,2-trifluoroethanesulfo 
nyl chloride (tresyl chloride) and 2 ml. of triethylamine 
for 15 minutes at room temperature. 
3. Rinse-activated PET film was then rinsed with 
0.2M sodium bicarbonate pH 10 buffer at room temper 
ature to couple the peptide. 
4. Peptide Coupling to Surface-rinsed PET films 
were then placed in the same buffer containing 80 
mg/ml GRGD or GYIGSR peptide for 20 hours. 
Example 4-Primary Cell Culture From Human 
Foreskin Tissue 
Human foreskin fibroblasts (HFFs) are primary cell 
lines that were isolated from neonatal foreskin tissue 
from Seton Hospital, Neonatal Ward, Austin, Tex. The 
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following procedure was used to establish primary cell 
lines from these tissues: 5-10 foreskins were collected 
aseptically insterile PBS, minced into 5mm2 pieces, and 
incubated in trypsin-EDTA for 4 hours. HFFs were 
collected by centrifugation at 200 g for 5 minutes and 
resuspended in Dulbecco's modification of Eagle's me 
dium supplemented with 10% fetal calf serum. Cells 
were subcultivated by trypsinizing confluent monolay 
ers, suspending cells in fresh medium, and seeding cells 
into new flasks. HFFs were maintained in culture for up 
to 20 passages before they were discarded. 
Example 5-Cell Adhesion Studies On Derivatized 
PHEMA and PET Polymer Surfaces 
This experiment was designed to determine if a poly 
mer surface could be designed and synthesized which 
would support receptor-mediated cell adhesion in the 
absence of any intermediate adsorbed proteins, i.e., to 
produce a surface that was entirely self-sufficient in its 
support of cell adhesion and spreading. Immobilization 
of entire proteins, such as collagen or fibronectin, can 
accomplish this but is associated with the difficulties of 
proteolysis, protein degradation, and protein denatura 
tion. To circumvent this, the small, thermally stable 
peptide region of most CAMs, Arg-Gly-Asp (RGD) 
was covalently coupled to the surface of polymer films 
with a Gly N-terminal linker in the form of Gly-Arg 
Gly-Asp (GRGD). This produced stable surfaces that 
were intrinsically bioadhesive, i.e., the material surfaces 
contained groups with a high affinity for cell-surface 
receptors completely independent of adsorbed CAMs 
from the culture medium. This surface modification 
provided a systematic methodology for developing well 
characterized substrata which simplifies optimization of 
a culture system. Mouse NIH-3T3 (ATCC #CRL 1658) 
fibroblasts were washed and innoculated in serum-free 
medium on both treated and untreated PHEMA sub 
strata. Treated PHEMA substrata was prepared as out 
lined in Example 2. 
CULTURE METHODS 
NIH/3T3 fibroblasts (ATCC #CRL 1658, Rockville 
Md.) were cultured in DMEM supplemented with 10% 
calf serum in a humidified 5% carbon dioxide atmo 
sphere at 37° C. Porcine aortas were obtained from 
sacrificed miniature swine. Endothelial cells were iso 
lated by the method of Jaffe, et al. (1973, J. Clin, Invest., 
52: 2745-2756) with a modification to facilitate profu 
sion of the lumenal surface of the vessel with collage 
nase. Porcine aortic endothelial cells (PAE) were main 
tained in DMEM supplemented with 10% fetal calf 
serum with the same incubation conditions as above. 
Surface Modification Procedure 
GRGD was grafted on polymer surfaces via the gly 
cyl terminal amine using the tresyl chloride immobiliza 
tion method of Nilsson and Mosbach and as described in 
Examples 3 and 4. Two polymer surfaces were modi 
fied, poly(hydroxyethyl methacrylate) (abbreviated 
PHEMA) and poly(ethylene terephthalate) (abbrevi 
ated PET). The coupling method utilized activation of 
surface hydroxyl moieties by tresyl chloride in an or 
ganic solvent for the reaction components, which is also 
a nonsolvent for the polymer. The tresyl leaving group 
was then displaced in aqueous solvent by the terminal 
amine of the peptide. 
Poly(ethylene terephthalate) (PCT) has no available 













fore a surface hydroxylation procedure was developed. 
An electrophilic aromatic substitution which adds hy 
droxymethyl groups to the PET films was employed 
(FIG. 1). Specifically, the commercially available PET 
films were immersed in 18.5% (v/v) formaldehyde and 
1M acetic acid for four hours at room temperature, as 
particularly defined in Example 3. PHEMA films did 
not require pretreatment since their surfaces are amply 
supplied with hydroxyethyl groups. 
The modified PET and unmodified PHEMA films 
were tresyl activated in 20 ml dry ether containing 40 ul 
of 2,2,2-trifluoroethanesulfonyl chloride (tresyl chlo 
ride) and 2 ml of triethylamine for 15 minutes at room 
temperature. Activated films were then rinsed with 
0.2M sodium bicarbonate pH 10 buffer and placed in the 
same buffer containing about 80 ng/ml GRGD for 20 
hours at room temperature to couple the peptide. FIG. 
2 graphically depicts a modified PET film with hy 
droxymethyl moieties and the subsequent steps in 
volved with tresyl activation and GRGD coupling. 
Cell Spreading Assay 
NIH/3T3 and PAE cells were detached from culture 
flasks by trypinsization and suspended in serum-free 
medium (DMEM with 1 mg/ml bovine serum albumin 
(BSA)). The cells were washed twice by centrifugation 
in the BSA containing medium and seeded at a density 
of 3,000 cells per cm2 of film, unless otherwise noted, in 
serum-free medium and incubated in the normal culture 
environment. Spread cells were scored by morphologi 
cal features such as distinct nuclei, pseudopodia, and 
polygonal shape (FIG. 3). Cells were visualized at 
200X magnification using Hoffman modulation con 
trast optics on a Leitz Fluovert inverted stage micro 
scope. Cell growth was also assessed by determining 
spread cell counts at various time points, for cells cul 
tured in media supplemented with 10% calf serum. 
Actin Stress Fiber Visualization 
NBD Phallacidin (7-nitrobenz-2-oxa-1,3-diazolyl 
phallacidin) (Molecular Probes, Inc. Eugene, Ore.) was 
employed to visualize actin stress fibers and microfila 
ment bundles in cells attached to the modified surfaces. 
Samples were prepared according to the manufacturer's 
procedure and 1000X images were viewed utilizing the 
Fluovert microscope equipped with a Leitz E3 excita 
tion filter and UV illumination. 
Soluble Peptide Competition Studies 
In the competition studies, 3T3 fibroblasts were 
preincubated for 30 minutes in either serum-free me 
dium containing about 90 ug/ml RGDS or no peptide. 
The cells were then inoculated at a density of about 
3000 cells/cm2 on GRGD derivatized PET and spread 
ing was determined after three hours incubation under 
normal culture conditions. 
The GRGD derivatized substrates were character 
ized by their ability to support active adhesion of cells 
on their surfaces. The PET pretreatment was optimized 
by coupling GRGD to tresyl chloride activated films 
that were hydroxylated for various time periods. Cell 
spreading assays using NIH/3T3 fibroblasts were per 
formed to determine conditions that supported a maxi 
mal response. Four hours pretreatment appeared to be 
optimal for maximum cell adhesion and spreading. 
PHEMA films were derivatized with GRGD utilizing 
low concentrations of peptide (80 ng/ml) which re 
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sulted in an increase in cellular adhesion by three orders 
of magnitude (FIG. 4). 
Comparison of GRGD coupled PET films with pre 
treated untresylated films that were incubated with 
GRGD for the normal coupling time demonstrated that 
either little peptide adsorbed to the latter films or that 
the adsorbed peptide was not available for the receptor 
mediated adhesion response (FIG. 5). The GRGD mod 
ified surfaces supported much better 3T3 cell adhesion 
than the untreated PET even in the presence of serum, 
which is indicative of an intrinsic activity on the modi 
fied surface (FIG. 6). 
The competition experiment resulted in a 75% reduc 
tion of attachment to the modified surfaces in the pres 
ence of about 90 ug/ml RGDS, which further demon 
strates the biospecific activity of the substrates (FIG. 7). 
Gross morphology (FIG. 3) of spread 3T3 fibroblasts in 
serum-free medium on the modified films appeared 
normal (FIG. 3). 
These results indicate that the complete adhesive 
response of this cell line and others is not obtained on 
RGDS modified surfaces. This is not a general phenom 
enon however, as some cell types including normal rat 
kidney fibroblasts and Nil 8, a normal hamster fibroblast 
cell line, have been shown to fully respond to substrates 
containing only RGD peptides (14). Growth on the 
GRGD derivatized-PET was serum dependent and was 
similar to that on unmodified PET (FIG. 8), but the 
initial attachment and spreading was more rapid, as 
indicated by the observation, that the GRGD curve 
leads (open boxes) the control curve (solid diamonds) in 
this figure. 
Attachment and spreading of porcine aortic endothe 
lial cells on the GRGD coupled surfaces was also serum 
independent as expected, since vascular endothelial 
RGD directed receptors have been characterized (15). 
PAE cell spreading in complete medium was much 
more extensive on the GRGD derivatized films than the 
untreated films at four hours, but both surfaces had 
confluent monolayers of cells at twenty four hours. 
These observations indicate that the kinetics of PAE 
cell attachment was more rapid on the modified surface. 
Applicants' disclosed methods provide a means for 
obtaining stable, chemically defined surfaces for use in 
studying cellular responses to insoluble extracellular 
matrix signals. It provides a means by which to de 
couple cell adhesion and spreading from protein adsorp 
tion. In this sense, it may be useful for those who prefer 
to use serum-free cell culture media (i.e., media in 
which purified proteins are added individually rather 
than introduced from serum) in that cell adhesion mole 
cules (CAMs) do not need to be included. Whether 
these surfaces are capable of supporting cell growth at 
very low serum concentrations remains to be deter 
mined. 
It should be understood that, in the presence of the 
media proteins, the GRGD surface is rapidly covered 
by adsorbed proteins. This is not problematic, however, 
as Applicants' studies with albumin in the culture media 
(FIGS. 4, 5, 7) indicated that the high affinity RGD 
integrin association is capable of ccmpeting favorably 
with the adsorbed proteins. Cell detachment may be 
accomplished by calcium chelation, as the RGD-inte 
grin affinity is calcium dependent. 
It should also be noted that cell function is highly 
dependent upon the cell attachment surface (16, 17). 













closer to the one in vivo, and hence stimulate stronger 
adhesion and/or higher productivity. 
Example 6-Peptide Derivatization of a Glass Surface 
The present example was designed to outline the most 
preferred method of derivatizing a ceramic surface, 
such as glass, to provide a cell receptor-mediated adhe 
sion-promoting substrate. 
Glycophase glass was prepared by the method of 
Ohlson et al. (18). Glass coverslips (18 by 18 mm; 
Thomas) were soaked in 0.5 M sodium hydroxide for 
two hours, rinsed in deionized water, and immersed in 
an aqueous solution (1% pH 5.5) of (3-glycidoxy 
propyl)trimethoxysilane (Petrarch Systems, Inc.). The 
preparation was heated and maintained at 90° C. for 2 
hours. The pH was then adjusted to 3.0 followed by 
heating again for 1 hour to convert the oxirane moieties 
on the derivatized glass to glycol groups. Dry glyco 
phase glass coverslips were rinsed with dry acetone 
(dried over molecular sieve 4A; Fisher). To about 1 ml 
of dry acetone, about 200 ul of dry pyridine and about 
100 ul of dry tresyl chloride (Fluka) were added. A 
minimal volume of this mixture was added to the upper 
surface of each glycophase glass coverslip placed in a 
glass crystallization dish. The reaction was allowed to 
proceed for about 10 minutes at room temperature, then 
the coverslips were rinsed in about 1 mM hydrochloric 
acid and finally rinsed in an about 0.2 M sodium bicar 
bonate buffer at pH 9 (coupling buffer). Coupling buffer 
containing between about 5-30 ng/ml of peptide, pref 
erably about 10 ng/ml, was added at a minimal volume 
on the coverslips and incubated for about 20 hours at 
room temperature to graft the peptide to the surface. 
The peptides used in this study were synthesized as 
outlined in Example 1. The peptide containing buffer 
was removed after an about 20 hour incubation period 
and replaced with coupling buffer containing an about 
0.8 M beta-mercaptoethanol. The coverslips were incu 
bated for about 2 hours so that unreacted tresyl groups 
would react with a nonadhesive moiety. 
Measurement of Peptide surface concentration 
GRGDY was radiolabeled by adding about 20 ug of 
peptide to phosphate buffered saline, pH 7.4, containing 
about 5.0 mCi of Na25I and incubating for about 15 
minutes at room temperature with Iodobeads (Pierce) 
according to the manufacturer's instructions. The la 
beled peptide was purified by loading the reaction mix 
ture on a Sep-Pak C18 sample preparation cartridge 
(Waters) that was washed with methanol-H2O-tri 
fluoroacetic acid (TFA) (80:19:1 v/v) and reequili 
brated with PBS. The cartridge was washed with 1% 
v/v TFA to eluate unincorporated iodine. The reaction 
mixture was fractioned using 10% stepwise increases in 
methanol concentration in 1% TFA with the methanol 
H2O-TFA (80:19:1 v/v) as the final eluant. The car 
tridge was washed with each concentration until the 
radioactivity returned to a baseline level. Each fraction 
was analyzed for peptide content by measuring absor 
bance at 220 nm (epsilon=8441 M-1 cm). Greater 
than 90% of the eluted peptide was in the methanol 
H2O-TFA (40:59:1 v/v) fraction, which was lyophi 
lized and reconstituted in PBS. The specific activity of 
the peptide was then determined after counting a 
known amount of labeled peptide in an automatic 
gamma counter (Isoflex, ICN Micromedic Systems). 
The average specific activity was 44.0+2.0 mCi/mmol. 
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To determine peptide surface concentrations, radiola 
beled peptide was added to coupling buffer (0.2M so 
dium bicarbonate, pH 10) at various concentrations, and 
incubated for 20 hours on tresyl activated glass at room 
temperature. Input concentrations were defined as the 
moles of soluble peptide available for reaction per unit 
area of glass surface. Surface concentrations were de 
fined as the moles of peptide coupled per unit area of 
glass and were determined by counting washed glass 
samples in a gamma counter and calculating the values 
based on the specific activity of the labeled peptide. 
The synthetic peptides Gly-Arg-Gly-Asp-Tyr 
(GRGDY) and Gly-Tyr-Ile-Gly-Ser-Arg-Tyr 
(GYIGSRY), which contain the ligands for two impor 
tant classes of cell adhesion receptors, were covalently 
coupled to the non-adhesive modified glass surface, 
glycerol propylsilane bounded glass (glycophase glass) 
by the N-terminal Gly. Glycophase glass contains a 
covalently bound organic layer that imbibes water and 
reduces protein adsorption similar to hydrogels without 
the associated problems of swelling and bulk perme 
ation of aqueous solutions. Since glycophase glass ab 
sorbs proteins poorly, it alone is not suitable for sup 
porting cell adhesion, even with serum in the medium. 
Therefore, GRGDY and GYIGSRY were coupled to 
glycophase glass using the tresyl chloride immobiliza 
tion method of Nilsson, et al. (1987), Methods Enzymol, 
135:65-78). The Nilsson, et al. article is specifically 
incorporated herein by reference. 
The N-terminal "G' was used as a spacer between 
the adhesive peptide and the surface, and the C-terminal 
"Y" was used for radioiodination. Since primary amines 
serve as nucleophiles that react and covalently bind to 
tresylchloride-activated supports, the peptides em 
ployed linked to the glycophase glass exclusively 
through the primary amine of the N-terminal "G". The 
surface concentration of peptide was measured by I 
radiolabeling and was 12.1 picomoles/cm2. This deri 
vatization method produces chemically stable sub 
strates, which may be useful in studying receptor 
mediated cell adhesion, as the quantity of peptide avail 
able at the surface may be precisely measured and con 
trolled. 
Example 7-Adhesion and Spreading of Cells on a 
Peptide Derivatized Glass Surface 
The present examples was designed to determine the 
effectiveness of the proposed chemical glass surface 
treatments in promoting the amount and rate of cell 
adhesion to a glass surface. 
Substrate Preparation 
Glycophase glass substrates were prepared by the 
method described in Example 6. These modified sub 
strates supported the adhesion and spreading of cul 
tured human foreskin fibroblasts (HFFs) independently 
of adsorbed proteins. 
Parameters Measured 
The biological activity of both grafted GRGDY and 
GYIGSRY was assessed by measuring the adhesion and 
spreading of HFF in the presence and absence of serum 
in the medium. Focal contact formation and cytoske 














HFF spreading rates were much slower on grafted 
YIGSR (GYIGSRY) peptide substrates than on the 
RGD-containing (GRGDY) peptide surfaces. Cells 
formed focal contacts or absence on the RGD-deriva 
tized substrates in the presence of serum. Focal contacts 
formed on &:he YIGSR-grafted surfaces only when 
serum was present in the medium and had morphologies 
distinct from those observed on the RGD-containing 
surfaces (FIG. 10; FIG. 12). 
Serum influenced microfilament organization and the 
extent of spreading of adherent cells, although adsorp 
tion of adhesion proteins was minimal on all surfaces. 
Example 8-Comparative Studies of Peptide 
Fragments GRDGY, GYGSRY and GRGEY on a 
Derivatized Glass Surface 
Derivatized glass surfaces were prepared according 
to the method described in Example 6 employing the 
GRGDY, GRGEY and GYGSRY peptides. HFF cells 
were then platted onto each of the prepared surfaces. 
Spreading and growth rate determinations were then 
made. Untreated glycophase glass was found to support 
no cell adhesion, even when cells were incubated on 
this substrate in serum-supplemented medium, which is 
indicative of a low protein-binding substrate (Table 1). 
Beta-mercaptoethanol-grafted glass was equally non 
supportive of cell adhesion and spreading, as indicated 
in the results of the cell spreading studies (FIGS. 2B, 
D, 3 B, D). Since beta-mercaptoethanol was employed 
to react with any remaining tresyl groups on the surface 
of the glass, a non-adhesive background was established 
on this surface. Furthermore, grafted GRGEY, which 
does not intrinsically support receptor-mediated cell 
adhesion and adsorbs proteins similarly to grafted 
GRGDY, did not support cell adhesion (Table 1). This 
result suggests that immobilizing GRGDY on glyco 
phase glass does not significantly enhance protein ad 
sorption on this substrate. 
Spreading and Growth Rate Determination 
HFF cells were prepared as outlined in Example 4. 
These cells were harvested for experiments and rinsed 
twice with Ca2+- and Mg2+-free phosphate buffered 
saline (PBS) and then incubated in 0.05% trypsin plus 
0.53 mM EDTA in PBS (GIBCO) for 10 minutes. Cells 
were collected by centrifugation and resuspended in 
serum-supplemented medium or serum-free medium 
which consisted of DMEM with 2 mg/ml of heat-inac 
tivated (90° C., 10 min.) albumin (Sigma) and antibiot 
1CS. 
Cells suspended in complete or serum-free medium 
were seeded on the substrates at a density, of about 
10,000 cells/cm2 and allowed to attach and spread at 37 
C. in 5% CO2. An inverted microscope (Fluovert, 
Leitz) equipped with a phase contrast objectives and a 
high resolution video camera (67M series, Dage-MTI) 
were used to visualize spreading cells at various time 
points. 
Images were digitized with an image processing sys 
ten (Series 150, Imaging Technology Inc.) and the 
areas of individual cells were determined by tracing the 
perimeter of each cell in the digitized images with a 
tracing pad (Digi-Pad, GTCC) and computing the area 
enclosed by each trace with an integration routine. At 
least 100 cells were analyzed and cumulative histograms 
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were constructed for each time period so that cell 
spreading rates could be determined. 
Cell growth in complete medium on substrates was 
assayed by visualizing cells with 100X phase contrast 
microscopy. At various time points, cells were counted 5 
in ten fields and the number of cells power unit area of 
growth surface was calculated based on an averaged 
cell count per area of field. 
In the end point cell spreading assays protein synthe 
sis was inhibited by treating cells with 20 ug/ml of 10 
cycloheximide for about 30 minutes prior to inoculating 
them on substrates. The cells were maintained in me 
dium containing cycloheximide throughout the experi 
ment. Cells that were treated with soluble peptide were 
preincubated with medium containing peptide for about 15 
30 minutes and were maintained in that medium 
throughout the experiment. Spread cells were scored in 
10 fields according to methods described by Massia et 
al. (1989) (Biochem. Engin. VI, Ann, N.Y. Acad. Sci., in 
press). The percentage of spread cells per field was 20 
calculated by multiplying the ratio of spread cells to the 
total number of cells per field by 100. 
Morphological Studies 
Cells adherent to peptide-grafted 24X50 coverslips 25 
(Thomas) were mounted in a culture chamber stage and 
fitted on the Fluorovent inverted microscope. A NPL 
Fluotar 100X (Leitz) objective was employed so that 
transmission phase contrast, and interference reflection 
(IRM) microscopy could be performed on the same 30 
field without changing objectives. Phase contrast and 
IRM images were acquired from live cells immersed in 
medium and maintained at 37 C. Illumination for phase 
contrast was provided by a 100W halogen lamp and a 
model 050260 power supply (Leitz) equipped with a 
heat-reflecting filter. A 100W mercury arc lamp pow 
ered by a HBO 100 model 990023 DC source (Leitz) 
was used for IRM. Images were acquired with a high 
resolution video camera (70 series, Dage-MTI) and 
digitized with the Series 150 image processing system. 40 
Digitized images were photographed from a high reso 
lution video monitor (model PVM 1271O, Sony) using 
Ilford Pan F film. 
Fluoresence Microscopy 
Cells on peptide-grafted glass coverslips at the end of 45 
incubation times were rinsed in PBS and fixed for about 
20 minutes with 3.7% (v/v) formaldehyde in PBS. 
They were then rinsed in PBS and permeabilized by 
incubation at room temperature for about 1 minute in so 
PBS containing about 0.2% (v/v) TRITON X-100. 
Cells were then rinsed in PBS and stained for F-actin 
with a 20 minute incubation at room temperature with 
about 900 ng/ml rhodamine-conjugated phalloidin 
(Molecular Probes, Inc.). The coverslips were rinsed 
thoroughly with PBS and mounted on microscope 
slides in 50% PBS-50% glycerol These preparations 
were viewed and photographed on the Fluovert micro 




Determination of GRGDY Surface Concentration 
The number of reactive sites and the corresponding 
peptide concentration on the surface were determined 
by titration with the radiolabeled GRGDY (FIG. 9). 
Surface concentration of grafted GRGDY was deter 
mined to increase linearly with increasing concentra 
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tions of peptide available for coupling to the surface, 
reaching a maximum value of 12. it0.1 picomoles/cm2 
(FIG. 9). Subsequent increases in input peptide concen 
trations above 12.0 picomoles/cm did not further in 
crease the surface concentration of the peptide. A maxi 
mum surface concentration of 12.1 picomoles/cm2 cor 
responds to a surface coverage of 73,000 molecules per 
square micrometer, or a spacing of approximately 3.3 
nm between peptides. 
HFF Spreading Rates on Peptide-Grafted Substrates 
Cells were observed to spread progressively during 
the 2 hour period on the RGD-derivatized glass, both in 
the presence and absence of serum, with 50% of the 
cells analyzed having areas of 2130 un? or less 2 hours 
after seeding in complete medium (FIG. 10A), and 50% 
of the cells having areas 1210 um or less 2 hours after 
seeding in serum-free medium (FIG. 10C). The average 
area of a well-spread cell on tissue culture plastic in 
complete medium was observed to be 2100 um, 
whereas a non-spread cell had an average area of 355 
um2. The area ranges of cells cultured on the nonadhe 
sive surfaces did not vary over time in the presence or 
absence of serum, with 50% of the cells having areas 
less than 500 um2 (FIGS. 10B, D). These results indicate 
that no spreading occurred on these surfaces, and most 
of the cells were observed to be nonadherent. 
Cell spreading was also observed on YIGSR-deriva 
tizing glass in the presence and absence of serum. 
Spreading rates were much slower on grafted YIGSR 
substrates than on the RGD-containing surfaces, requir 
ing more than 6 hours for complete spreading in com 
plete (FIG. 10A) or serum-free (FIG. 10B) medium. 
After about 9 hours in serum-free medium, 50% of the 
cells analyzed had areas 1400 um2 or less (FIG. 10B), 
which is comparable to areas of well-spread HFFs on 
the RGD surfaces in serum-free medium. Serum was 
observed to enhance cell spreading on the YIGSR sur 
faces; 50% of the cells analyzed had areas of 2333 um? 
or less (FIG. 10A) 9 hours after inoculation. Nonadhe 
sive control surfaces were identical to the ones prepared 
for the RGD-derivatized glass studies and cell spread 
ing was not observed on these surfaces; 50% of the cell 
areas never exceeded 600 um2 throughout the time 
frame of the study (FIGS. 10C, D). 
Effects of Grafted GRGDY on Cell Growth 
The effect of these RGD-containing substrates on 
cell growth was checked by monitoring growth of 
HFFs seeded on glass containing coupled GRGDY. No 
difference in growth rate was observed when we com 
pared growth of cells cultured on RGD-derivatized 
glass with that of untreated (not glycophase) glass 
(FIG. 11). 
Characterization of Cellular Responses to the 
Peptide-Grafted Substrates 
Since serum enhanced cell spreading on the peptide 
containing glass, it was postulated that the peptides 
grafted to the surface of the nonadhesive glass pro 
moted the adsorption of serum and excreted cellular 
proteins which would augment cell adhesion and 
spreading on these substrates. To check this possible 
effect, the synthetic peptide GRGEY was coupled to 
glass, and cell spreading on these surfaces was assayed. 
The substitution of glutamic acid (E) for aspartic acid 
(D) (an addition of one methylene group to the carbox 
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ylic acid side chain) has been demonstrated to abolish 
the adhesion-promoting activity of the peptide (8) but 
should have little impact on the way the peptide inter 
acts with potentially adsorbing proteins. 
No cell spreading was observed on covalently bound 
GRGEY after about 8 hours, even when complete me 
dium was used and cellular protein synthesis was not 
inhibited (Table 1). These findings suggest that the 
covalently-bound GRGEY peptides do not signifi 
cantly increase the adsorption of cell adhesion proteins 
which would promote and enhance cell spreading. This 
is to say that, the cell adhesive behavior of the peptide 
grafted surfaces was due to the peptide's affinity for 
cell-surface receptors and not due to enhanced serum 
protein adsorption by the peptide. 
To determine if protein synthesis played a role in cell 
spreading on the RGD and YIGSR-linked substrates, 
and if serum significantly increased the fraction of cells 
that spread at a time point where spreading was com 
plete, the percentage of spread cells was determined on 
each surface under different conditions after an 8 hour 
incubation period. It was observed that neither protein 
synthesis nor the presence of serum in the medium af. 
fected the fraction of cells spread on the RGD-and 
YIGSR-derivatized glass (Table 1). Cell spreading on 
both the peptide-grafted surfaces was completely inhib 
ited, however by the presence of soluble peptide in the 
medium (Table 1), indicating that cellular adhesion on 




grafted Serum in heximide Peptide Spread 
to medium in medium in medium cells 
surface (10% v/v) (20 ug/ml) (200 ug/ml) (%) 
GRGEY -- -- - 0 
-- - - 0. 
-- -- O 
m - - O 
GRGDY -- - - 87 - 8 
-- -- - 809 
m --- - 91 4 
-- -- - 83 - 10 
--- --(RGDS) O 
- -- --(RGDS) O 
GYGSRY -- - - 78 7 
-- -- - 82 - 2 
- - - 81 - 12 
-- - 90 2 
- +(YIGSRY) O 
m -- +(YIGSRY) 0 
Cell-Substrate Contacts and Cytoskeletal Organization 
Cells were examined live by IRM and phase contrast 
microscopy at about 4 hours after seeding on RGD 
derivatized substrates and about 8 hours after seeding 
on YIGSR-derivatized substrates. Fixed specimens 
were stained with rhodamine-conjugated phalloidin to 
evaluate microfilament distribution in spread cells. All 
images were digitized and a high pass filter was em 
ployed to enhance detail. 
Cells seeded in the absence of serum on RGD-grafted 
glass, formed small, round focal contacts that were 
observed mainly on the outer margins of cells (FIG. 
13B). Serum supplemented medium supported forma 
tion of large elongated focal contacts typical of cells 
that spread on cell adhesion molecule-coated substrates 
(FIG. 13D). Cells spreading on YIGSR-grafted glass 
did not form focal contacts in the absence of serum 
(FIG. 14B). Focal contacts were well-defined on this 
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(FIG. 14D), however they were morphologically dis 
tinct from those of FIG. 13D on the RGD-derivatized 
substrates. Focal contacts on the YIGSR-derivatized 
substrates were elongated, similar to those in FIG. 13D, 
but were predominantly located in the outer margins of 
cells. Phase contrast images (FIGS. 13A, C; 14A, C) did 
not reveal any obvious morphological differences be 
tween spread cells on the various substrates, but serve 
as a corresponding image for the IRM images. 
Rhodamine-phalloidin staining revealed an extensive 
network of acting microfilament bundles in spread cells 
on RGD-grafted glass, that were incubated in serum 
free (FIG. 15A) or complete (FIG. 15B) medium. Bun 
dles formed by spreading cells incubated in serum sup 
plemented medium stained more intensely than those 
formed by cells incubated in serum-free medium, which 
indicates that thicker fibers formed when serum was 
present. Cells incubated in serum-free medium on the 
YIGSR-grafted substrates formed very few microfila 
ment bundles (FIG. 15C), however thick bundles 
formed when serum was present in the medium (FIG. 
15D). 
These studies show that adhesion-promoting syn 
thetic peptides of minimal sequences can be covalently 
grafted to the surface of a nonpermeable, nonadhesive 
material such as glycophase glass to produce biologi 
cally active, chemically well-defined surfaces that sup 
port cell adhesion. These substrates may be useful in the 
study of cell adhesion, as the amount of peptide avail 
able on the surface may be precisely measured (FIG.9) 
and it is possible to control the amount of peptide 
grafted competitively by adding controlled amounts of 
a nonadhesive species, such as glycine, in the coupling 
buffer. This could be an important requirement for 
model substrates of receptor-mediated cell adhesion, 
since it has been recently shown that integrin-mediated 
cell adhesion to adsorbed RGD-albumin conjugates is 
very sensitive to the density of RGD-containing groups 
that are covalently attached to the native protein. 
Example 9-Stability of Peptide-Grafted Substrates 
Radiolabeled GRGDY peptides were covalently 
grafted to glycophase glass substrates in order to deter 
mine how stable the immobilized peptides were to heat 
and proteolysis. The percent (%) loss in radioactivity 
was interpreted to indicate the percent (%) of immobi 
lized peptide that was degraded and thus unavailable for 
enhancing cell adhesion. 
The data suggests that these peptide-grafted sub 
strates are quite stable to autoclaving (steam steriliza 
tion at 121 C.), since no loss of radioactivity was evi 
dent after this treatment (Table 2). Also, no radioactiv 
ity was lost after culturing cells on these substrates for 
1 week. The data also indicates that the treated sub 
strates are stable to cellular proteases. 
TABLE 2 
Stability of RGD-derivatized Glycophase Glass 
Environmental Stress 
to the Substrate % loss of radioactivity 
Autoclave (121 C., 15 min) 0 -- 0 
Cell Culture (1 week) 2 - 1 
Exposure to Trypsin 5 -- 4 
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Example 10-Peptide Adsorption Comparison of 
GRGD Coupled PET Substrates With Pretreated 
Untresylated PET Substrates 
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as described in Example 3 by tresyl activation and cou 
pling. The fur of the animal would be shaved along the 
abdomen, and the skin opened with a lateral cut of 
about 1 cm length. The catheter would be inserted into 
The GRGD derivatized PET substrates were charac- 5 a vein, e.g. the descending vena cava, and the cuff 
terized by their ability to support active adhesion of 
cells on their surfaces. The PET pretreatment was opti 
mized by coupling GRGD to tresyl chloride activated 
films that were hydroxylated for various time periods. 
Cell spreading assays using NIH/3T3 fibroblasts were 
performed to determine conditions that supported a 
maximal response. An about four hour pretreatment 
appeared to be optimal for maximum cell adhesion and 
spreading (FIG. 17). 
Comparison of GRGD coupled PET films with pre 
treated untresylated films that were incubated with 
GRGD for the "normal” coupling time (about 20 
hours) demonstrated that either little peptide adsorbed 
to the film or that the adsorbed peptide was not avail 
O 
15 
able for the receptor mediated adhesion response (FIG. 20 
5). The GRGD modified surfaces supported much bet 
ter 3T3 cell adhesion than the untreated PET, even in 
the presence of serum, which is indicative of an intrinsic 
activity on the modified surface (FIG. 6). The competi 
tion experiment resulted in a 75% reduction of attach 
ment to the modified surfaces in the presence of about 
90 ug/ml RGDS, which further demonstrates the bios 
pecific activity of the substrates (FIG. 7). 
Gross morphology (FIG. 3) of spread 3T3 fibroblasts 
in serum-free medium on the modified films appeared 
normal, however, microfilament bundle and stress fiber 
formation could not be detected under these conditions. 
These results indicate, as others have shown with ab 
sorbed RGD peptides (19, 20, 14), that the complete 
adhesive response of this cell line and others is not ob 
tained on these modified surfaces. This is not a general 
phenomenon however, as some cell types including 
normal rat kidney fibroblasts and Nil 8, a normal ham 
ster fibroblast cell line, have been shown to fully re 
spond to substrates containing only RGD peptides (14). 
Growth on the GRGD derivatized PET was serum 
dependent and was similar to that on unmodified PET 
(FIG. 8), but the initial attachment and spreading was 
more rapid, as indicated by the observation that the 
GRGD curve leads the control curve (FIG. 8). 
Attachment and spreading of porcine aortic endothe 
lial cells on the GRGD coupled surfaces was also serum 
independent (FIG. 16). As expected, since vascular 
endothelial RGD directed receptors have been charac 
terized (15). PAE cell spreading in complete medium 
was much more extensive on the GRGD derivatized 
films than the untreated films at four hours, but both 
surfaces had confluent monolayers of cells at twenty 
four hours. These observations indicate that the kinetics 
of PAE cell attachment was more rapid on the modified 
surface. 
Example 11-An Indwelling Catheter with a 
Bioadhesive Dacron Velour Cuff in a Rabbit 
(Prophetic) 
Adacron velour cuff with an inner diameter of about 
1 mm and an outer diameter of about 3 mm would be 
placed around a polyethylene catheter at the base and 
glued in place with surgical-grade cement. Prior to 
placement a cuff would be treated in the acetic acid/for 
maldehyde solution as described in Example 3 to hy 
droxylate the surface. The tetrapeptide GRGD would 









would be placed just beneath the skin. The skin would 
be sutured together around the protruding catheter, 
such that it covered the cuff. The rates of bacterial 
infection on the catheter would then be measured. Sev 
eral of the cuffs would be removed after a period of 
time, for example, 1, 2, 3 and 4 weeks for histological 
examination of tissue integration, regrowth, and inflam 
mation. Control experiments would utilize unmodified 
dacron cuffs. 
Example 12-A Nerve Regrowth Guide (Prophetic) 
A polymer tube with a high permeability to water 
and oxygen with an inner diameter of about 1.5 mm and 
an outer diameter of about 3 mm would be used as a 
nerve regrowth guide in the rat. An example of a useful 
material would be poly(hydroxylethyl methacrylate). 
The lumen of the tube would be activated and coupled 
with the peptide GRGD or GYIGSR as described in 
Example 3. A nerve bundle in one leg would be severed 
and a section approximately 1 cm long would be re 
moved. Both ends of the nerve bundles would be in 
serted into the ends of the tubular regrowth guide, and 
the edges of the guide would be tightly sutured to the 
epiaxonal tissue. The wound would be closed, and rein 
nervation would be measured electrophysiologically 
weekly. Control experiments would utilize unmodified 
poly(hydroxyethyl methacrylate) tubes. 
The following references are cited throughout the 
Specification, and are hereby specifically incorporated 
in pertinant part by reference herein. 
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What is claimed is: 
1. A cell culture substrate of less than about 45% 
water comprising a surface with the terminal amine of a 
peptide covalently linked thereto, wherein said peptide 
is at least one of 10 
GRGD; GRGDY; GREDVY; or 
GRGDF, GYIGSR; GREDV, 
GRGDS; GYIGSRY; 15 
and wherein the surface concentration of said peptide is 
less than about 50 pmol/cm2, said substrate being capa 
ble of supporting cell focal adhesion formation and cell 
spreading. 
2. The cell culture substrate of claim 1, wherein said 
peptide comprises 4 to 6 amino acid residues. 
3. The cell culture substrate of claim 1 wherein the 
peptide is GRGD, GRGDY or GYIGSRY. 
4. The cell culture substrate of claim 1 wherein the 
peptide is GRGD, GRGDY, or GYIGSRY and is co 
valently attached to said cell culture substrate at the 
N-terminal glycine of the peptide. 
5. The cell culture substrate of claim 1, wherein said 
peptide is GRGD, GRGDF, GYIGSR, GYIGSRY 
GREDV or GREEDVY. 
6. The cell culture substrate of claim 1 or 5, wherein 
the peptide is GRGD. 
7. The cell culture substrate of claim 1 or 5 wherein 
the peptide is GYIGSR. 
8. The cell culture substrate of claim 1, wherein the 
peptide is GRGDY or GYIGSRY peptide. 
9. The cell culture substrate of claim 1 wherein the 
peptide is attached to the substrate at a surface concen 
tration of between about 0.5 picomoles/cm2 to about 50 
picomoles/cm2. 
10. The cell culture substrate of claim 1, wherein the 
peptide is attached to the substrate at a surface concen 
tration of between about 0.5 picomoles/cm2 to about 20 
picomoles/cm2. 
11. The cell culture substrate of claim 1, wherein the 
peptide is attached to the substrate at a surface concen 










12. The cell culture substrate of claim 1, wherein the 
substrate comprises a material selected from the group 
consisting of: 
a ceramic; 
a polymer; and 
a metal. 
13. The cell culture substrate of claim 12 wherein the 
metal is titanium. 
14. The cell culture substrate of claim 1, wherein the 
substrate comprises: 
a polymer; or 
a ceramic. 
15. The cell culture substrate of claim 1 or 5 wherein 
the substrate comprises a ceramic material. 
16. The cell culture substrate of claim 15, wherein the 
ceramic is glass. 
17. The cell culture substrate of claim 16, wherein the 
glass comprises glycerol propylsilane-bonded glass. 
18. The cell culture substrate of claim 16, wherein the 
polymer is poly(hydroxyethyl methacrylate). 
19. The cell culture substrate of claim 1, wherein the 
substrate comprises a polymer selected from the group 
consisting of: 
a plastic; 
a poly (hydroxyethyl methylacrylate); 
a poly (ethylene terephthalate); 
a poly (tetrafluoroethylene); 
a fluorinated ethylene; and 
a poly (dimethyl siloxane). 
20. The cell culture substrate of claim 19, wherein the 
polymer is poly(ethylene terephthalate). 
21. The cell culture substrate of claim 20, wherein the 
peptide is GRGD or GYIGSR. 
22. The cell culture substrate of claim 1 wherein the 
substrate is essentially free of peptide throughout the 
substrate bulk. 
23. The cell culture substrate of claim 22, wherein the 
peptide is within 10 nanometers of the substrate surface. 
24. A cell culture substrate capable of supporting 
fibroblast focal adhesion formation and spreading com 
prising a surface derivatized with a peptide consisting 
essentially of GYIGSR, wherein said peptide is cova 
lently linked by the terminal glycine to the surface. 
25. A cell culture substrate capable of supporting cell 
focal adhesion formation and cell spreading comprising 
a surface derivatized with a peptide selected from the 
group consisting of GRGD, GRGDF, GRDGY, 
GYIGSR and GYIGSRY, and wherein the terminal 
glycine of said peptide is covalently linked to surface 
hydroxyl groups of the surface. 
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